Professional
Added to YB: 2026-01-29
Pitch date: 2026-01-20
TEVA [neutral]
Teva Pharmaceutical Industries Limited
+6.81%
current return
Author Info
No bio for this author
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$39.6B
Pitch Price
$99.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.43
P/E
28.08
EV/Sales
3.09
Sector
Pharmaceuticals
Category
growth
Greenlight Capital Portfolio Holding: Teva Pharmaceutical Industries Limited
TEVA (holding update): Rapid growth in patented branded portfolio consistently exceeding expectations. Market reflecting progress after policy headwinds eased, including CMS pricing agreement for Austedo starting 2027. Progress offsets muted generics performance, highlights transition to branded pharma co.
Read full article (1 min)